NEUBERGER BERMAN GROUP LLC

Position in ASND — Ascendis Pharma A/S

CIK 1465109 NEW YORK, NY

Position in ASND

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$38,062,276

+$33,877,525 QoQ

Shares Held

142,705

+578.0% QoQ

Ownership

0.218%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#53

of 307 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NEUBERGER BERMAN GROUP LLC holds $1,452,567,393 across 97 Biotechnology names. ASND ranks #10 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	559,445	$277,893,114
2	REGN	Regeneron Pharmaceuticals, Inc.	421,976	$263,118,914
3	TECH	BIO-TECHNE Corp	2,844,692	$200,977,489
4	LGND	Ligand Pharmaceuticals Inc	248,355	$78,502,531
5	CAI	Caris Life Sciences, Inc.	3,590,963	$63,990,960
6	IONS	Ionis Pharmaceuticals Inc	633,533	$50,232,830
7	BBIO	BridgeBio Pharma, Inc.	552,158	$41,124,727
8	INSM	INSMED Inc	378,816	$40,389,361

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$38,062,276	142,705	+578.0%	Shares	Defined	2026-08-13
2025-09-30	$4,184,751	21,049	-9.4%	Shares	Defined	2025-11-12
2025-06-30	$4,010,187	23,234	-49.9%	Shares	Defined	2025-08-25
2025-03-31	$7,220,993	46,330	+21.5%	Shares	Defined	2025-05-13
2024-12-31	$5,249,218	38,129	-4.1%	Shares	Defined	2025-02-13
2024-09-30	$5,936,863	39,762	+31.2%	Shares	Defined	2024-11-14
2024-06-30	$4,131,767	30,296	-84.1%	Shares	Defined	2024-11-14
2021-03-31	$24,603,191	190,900	+46.3%	Shares	Defined	2021-05-13
2020-12-31	$21,764,790	130,500	+2.0%	Shares	Defined	2021-02-10
2020-09-30	$19,752,960	128,000	+20.8%	Shares	Defined	2020-11-12
2020-06-30	$15,677,400	106,000	+78.2%	Shares	Defined	2020-08-13
2020-03-31	$6,700,295	59,500	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.